Showing results 105 to 124 of 174
< previous
next >
| Issue Date | Title | Author(s) |
| 2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
| 2018 | A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study | Gül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf |
| Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
| Feb-2016 | A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| Jul-2016 | Molecular mechanisms of drug resistance and its reversal in cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
| Aug-2014 | Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2014 | Multidrug resistance in chronic myeloid leukemia | Ünlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf |
| Feb-2009 | Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients | Abaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk |
| 2012 | A natural product, quercetin enhances the cytotoxic and apoptotic effects of dexamethasone on jurkat cells | Baran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur |
| Feb-2013 | New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma | Kozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf |
| Oct-2015 | Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
| Feb-2010 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
| 2009 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
| 2012 | A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
| Jan-2013 | Novel agents targeting bioactive sphingolipids for the treatment of cancer | Adan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf |
| 2014 | A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17 | Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali |
| Nov-2011 | A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes | Gencer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| 2010 | A novel mechanism of nilotinib-induced apoptosis; bioactive sphingolipids | Baran, Yusuf ; Camgöz, Aylin; Gençer, Emel; Ural, Ali; Avcu, Ferit |
| 2015 | A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cells | Adan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf |
| 2008 | Optimization of transfection of green fluorescent protein in pursuing mesenchymal stem cells in vivo | Baran, Yusuf ; Ural, Ali Uğur; Avcu, Ferit; Sarper, Meral; Elçi, Pınar; Pekel, Aysel |
